PT  - JOURNAL ARTICLE
AU  - Shuman, Jill
ED  - Jorgensen, Daniel
TI  - Brilacidin
DP  - 2015 Jul 23
TA  - MD Conference Express
PG  - 11--11
VI  - 15
IP  - 48
4099  - http://mdc.sagepub.com/content/15/48/11.2.short
4100  - http://mdc.sagepub.com/content/15/48/11.2.full
AB  - Brilacidin is a novel host defense protein being studied for the treatment of community-acquired skin and soft tissue infections. A phase 2b trial shows that a single-dose injection of brilacidin is as effective as a 7-day dose of daptomycin in treating acute bacterial skin and skin structure infections associated with Staphylococcus aureus.